e-learning
resources
Virtual 2020
Pre-Congress Content
Pathophysiology and treatment of obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
IFN? involvement in adipogenesis of OSA patients
Y. Wang (Beijing , China), X. Zhang (Beijing , China)
Source:
Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Session:
Pathophysiology and treatment of obstructive sleep apnoea
Session type:
E-poster session
Number:
1336
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Wang (Beijing , China), X. Zhang (Beijing , China). IFN? involvement in adipogenesis of OSA patients. 1336
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Reduced expression of interferon stimulated genes in refractory asthma
Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease
Year: 2012
The role of obesity in patients with sarcoidosis
Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Year: 2019
Interleukin-17 cytokine signalling in patients with asthma
Source: Eur Respir J 2014; 44: 1319-1331
Year: 2014
Differential regulation of cytokine production is mediated by IL-17 in obese children with obstructive sleep apnoea
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
Interferon gamma (IFN?) pathway deficiency and severe NTM disease
Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease
Year: 2021
Is OSA an important risk factor for metabolic dysregulation in obese COPD patients
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Does APAP-therapy induce central apneas in OSAS patients?
Source: Eur Respir J 2005; 26: Suppl. 49, 725s
Year: 2005
Does diabetes mellitus affect T-cell interferon-gamma responses in TB patients?
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010
Increased CTGF expression of circulating fibrocytes in asthmatic patients with severe OSA - the role of HIF-1a and HDAC7
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018
Is OSAS a systemic disease?
Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)
Year: 2007
In-vivo and in-vitro production of interferon gamma in pediatric patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 140s
Year: 2002
Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 551s
Year: 2006
TLR7/8 regulates type I and type III interferon signalling in rhinovirus 1b-induced allergic asthma
Source: Eur Respir J, 57 (5) 2001562; 10.1183/13993003.01562-2020
Year: 2021
Antiviral biomarkers are upregulated in sputum cells following administration of inhaled interferon beta to COPD patients
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019
Increased interferon and decreased NRF2-PPARG signaling is associated with frequent exacerbations in COPD
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
R667 retinoid agonist modulates blood glucose in COPD
e
patients with improved metabolic profile compared to ATRA
Source: Annual Congress 2007 - New drugs for COPD
Year: 2007
Is classical OSA the same as OSA in other diseases ?
Source: 5th Sleep and Breathing Conference
Year: 2019
The involvement of thrombospondin-1 in COPD pathogenesis through IL-8 production
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Mild OSAS: Is CPAP therapy actually required for these patients?
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept